IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 228 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $434,070 | -36.1% | 95,400 | -1.1% | 0.73% | -44.2% |
| Q2 2023 | $679,360 | +128.3% | 96,500 | +98.2% | 1.31% | +143.6% |
| Q1 2023 | $297,557 | -2.6% | 48,700 | +1.7% | 0.54% | -14.4% |
| Q4 2022 | $305,602 | -66.3% | 47,900 | -49.4% | 0.63% | -66.2% |
| Q3 2022 | $907,000 | -28.5% | 94,650 | -18.3% | 1.85% | +34.3% |
| Q2 2022 | $1,268,000 | -43.4% | 115,870 | -14.0% | 1.38% | -16.9% |
| Q1 2022 | $2,240,000 | -21.3% | 134,679 | -9.7% | 1.66% | -41.4% |
| Q4 2021 | $2,848,000 | -21.1% | 149,181 | +1.9% | 2.83% | +4.9% |
| Q3 2021 | $3,609,000 | +86.7% | 146,362 | +97.1% | 2.70% | +89.1% |
| Q2 2021 | $1,933,000 | +705.4% | 74,275 | +748.5% | 1.43% | +440.5% |
| Q2 2020 | $240,000 | – | 8,754 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 565,890 | $26,257,000 | 9.39% |
| Consonance Capital Management LP | 1,710,803 | $79,381,000 | 7.41% |
| GREAT POINT PARTNERS LLC | 917,427 | $42,569,000 | 6.91% |
| Avoro Capital Advisors LLC | 7,500,000 | $348,000,000 | 5.99% |
| Ghost Tree Capital, LLC | 500,000 | $23,200,000 | 5.17% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $60,923,000 | 4.69% |
| Perceptive Advisors | 9,166,304 | $425,316,000 | 4.56% |
| Ally Bridge Group (NY) LLC | 360,000 | $16,704,000 | 2.86% |
| Orbimed Advisors | 6,645,100 | $308,333,000 | 2.70% |
| ACUTA CAPITAL PARTNERS, LLC | 164,800 | $7,647,000 | 2.08% |